LUMOS PHARMA, INC. — Operating Income by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/567f8fd2-737b-46d5-931a-5323cb06e0dd/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-36.6M | 2023-01-01 – 2023-12-31 | evidence 0001126234-24-000025 |
| FY 2022 | $-32.0M | 2022-01-01 – 2022-12-31 | evidence 0001126234-23-000035 |
| FY 2021 | $-31.3M | 2021-01-01 – 2021-12-31 | evidence 0001126234-22-000021 |
| FY 2020 | $-26.3M | 2020-01-01 – 2020-12-31 | evidence 0001126234-21-000034 |
| FY 2019 | $-9.8M | 2019-01-01 – 2019-12-31 | evidence 0001126234-21-000034 |
| FY 2018 | $-62.4M | 2018-01-01 – 2018-12-31 | evidence 0001126234-19-000026 |
| FY 2017 | $-72.9M | 2017-01-01 – 2017-12-31 | evidence 0001126234-18-000026 |
| FY 2016 | $-90.8M | 2016-01-01 – 2016-12-31 | evidence 0001126234-17-000025 |
| FY 2015 | $-33.6M | 2015-01-01 – 2015-12-31 | evidence 0001126234-16-000235 |
| FY 2014 | $117.6M | 2014-01-01 – 2014-12-31 | evidence 0001126234-15-000054 |
| FY 2013 | $-148.1M | 1999-06-05 – 2014-03-31 | evidence 0001126234-14-000116 |
| FY 2012 | $-115.7M | 1999-06-05 – 2013-03-31 | evidence 0001126234-13-000069 |
| FY 2011 | $-89.3M | 1999-06-05 – 2012-03-31 | evidence 0001126234-12-000024 |
| FY 2010 | $-16.7M | 2010-01-01 – 2010-12-31 | evidence 0001126234-12-000014 |
| FY 2009 | $-10.3M | 2009-01-01 – 2009-12-31 | evidence 0001126234-12-000014 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).